Margarete Focke-Tejkl

Title: Margarete Focke-Tejkl: Innovator in Allergy Vaccine Development

Introduction

Margarete Focke-Tejkl is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of allergy vaccines, holding a total of 5 patents. Her innovative work focuses on the development of peptide carrier fusion proteins that can serve as effective allergy vaccines.

Latest Patents

One of her latest patents involves peptide carrier fusion proteins designed as allergy vaccines. This invention relates to a polypeptide that comprises at least three peptide fragments, each consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen. These fragments are fused to the N- and C-terminus of a surface polypeptide of a virus from the hepadnaviridae family or at least one fragment of said surface polypeptide. This groundbreaking work aims to enhance the efficacy of allergy treatments.

Career Highlights

Throughout her career, Margarete has worked with notable companies such as Biomay AG and Mjn U.S. Holdings LLC. Her experience in these organizations has allowed her to further her research and development in the field of immunology and allergy treatment.

Collaborations

Margarete has collaborated with esteemed colleagues, including Rudolf Valenta and Susanne Vrtala. These partnerships have contributed to her success and the advancement of her research in allergy vaccines.

Conclusion

Margarete Focke-Tejkl is a trailblazer in the development of allergy vaccines, with a strong portfolio of patents and collaborations. Her work continues to impact the field of immunology positively.